Srs Capital Advisors, Inc. Immunity Bio, Inc. Transaction History
Srs Capital Advisors, Inc.
- $1.95 Billion
- Q2 2025
A detailed history of Srs Capital Advisors, Inc. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 600 shares of IBRX stock, worth $1,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
600
Previous 600
-0.0%
Holding current value
$1,500
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IBRX
# of Institutions
272Shares Held
120MCall Options Held
2.49MPut Options Held
3.14M-
Vanguard Group Inc Valley Forge, PA21.8MShares$54.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$28.6 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC8.76MShares$21.9 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.76MShares$19.4 Million0.36% of portfolio
-
Jane Street Group, LLC New York, NY7.72MShares$19.3 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...